Back to Search
PAUL SHAMI, MD
MD
Medical Oncology Physician
NPI: 1992895510IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
345232-1205(UT)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
345232-1205(UT)
Education
OTHER
Class of 1988
Research & Publications (20)
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).
PMID 19193435·Leuk Res·2009
8-other
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo.
PMID 16821795·J Med Chem·2006
7-preclinical
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.
PMID 12700285·Mol Cancer Ther·2003
7-preclinical
Identification and characterization of a novel gene that is upregulated in leukaemia cells by nitric oxide.
PMID 11167794·Br J Haematol·2001
8-other
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound.
PMID 19364650·Bioorg Med Chem Lett·2009
8-other
Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells.
PMID 19348908·Genomics·2009
8-other
Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.
PMID 18178089·Bioorg Med Chem Lett·2008
8-other
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.
PMID 17384201·Blood·2007
8-other
PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity.
PMID 16451080·J Med Chem·2006
7-preclinical
JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells.
PMID 16439016·Leuk Res·2006
8-other
Acute myeloid leukemia clinical practice guidelines in oncology.
PMID 16403402·J Natl Compr Canc Netw·2006
6-review
Pancreatic carcinoma surveillance in patients with familial melanoma.
PMID 12925390·Arch Dermatol·2003
5-case
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.
PMID 12756297·Proc Natl Acad Sci U S A·2003
8-other
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
PMID 12673719·Cancer·2003
3-trial
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity.
PMID 10649981·J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1950 CIRCLE OF HOPE DR
SALT LAKE CITY, UT 84112 - Phone
- (801) 581-2121
Quick Facts
- NPI
- 1992895510
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile